Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Infographic: Keeping tracking on track

    White Papers and Resources | December 7, 2016 | Inizio

    Our best practice approach to tracking studies.

    Lucid Group kick off their Winter Festival

    Press Releases | December 6, 2016 | Lucid Group Communications Limited

    The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

    What does the Five Year Forward View mean for pharma?

    White Papers and Resources | December 6, 2016 | Wilmington Healthcare

    Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.

    Healthcare in the Digital Age

    White Papers and Resources | December 3, 2016 | M3 (EU)

    Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

    M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

    Press Releases | December 3, 2016 | M3 (EU)

    M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs...

    Telehealth Research

    White Papers and Resources | December 1, 2016 | Inizio

    The remote exchange of data between patients and their clinician

    Leading Edge expands their senior medical writing team

    Press Releases | November 30, 2016 | Lucid Group Communications Limited

    Leading Edge, part of the Lucid Group specialising in strategic health communications and medical education, has bolstered its senior medical writing team with the new appointment of Jennifer (Jennie) Badger. Jennie...

    Web Summit Lisbon: Technology trends that will impact pharma

    White Papers and Resources | November 29, 2016 | Anthill Agency

    Digital technology is transforming every aspect of life. Here’s the most important trends pharma companies should watch, as observed by Anthill at Websummit earlier this month:

    Living with Crohn’s disease: a patient perspective

    White Papers and Resources | November 24, 2016 | Blue Latitude Health

    Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for...

    Lucid win PMEA Support Agency of the Year 2016

    Press Releases | November 24, 2016 | Lucid Group Communications Limited

    Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on...